ArticleBreast cancer research : BCR2022

Targeting SHP2 phosphatase in breast cancer overcomes RTK-mediated resistance to PI3K inhibitors.

Guus J J E Heynen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.